{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:49:05Z","timestamp":1790153345362,"version":"4.0.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2,15]]},"DOI":"10.1093\/hmg\/ddp535","type":"journal-article","created":{"date-parts":[[2009,12,4]],"date-time":"2009-12-04T01:44:02Z","timestamp":1259891042000},"page":"684-696","source":"Crossref","is-referenced-by-count":59,"title":["Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease"],"prefix":"10.1093","volume":"19","author":[{"given":"Gaelle","family":"Douillard-Guilloux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Raben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Takikita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Vignaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Guillet-Deniau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryline","family":"Favier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Thurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Caillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,3]]},"reference":[{"key":"key\n\t\t\t\t20170522140557_DDP535C1","first-page":"3389","article-title":"Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Hirschhorn","year":"2001"},{"key":"key\n\t\t\t\t20170522140557_DDP535C2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"key":"key\n\t\t\t\t20170522140557_DDP535C3","first-page":"91","article-title":"Glycogen storage disease type II: birth prevalence agrees with predicted genotype frequency","volume":"2","author":"Ausems","year":"1999","journal-title":"Community Genet."},{"key":"key\n\t\t\t\t20170522140557_DDP535C4","first-page":"53","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"7","author":"Raben","year":"1998","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522140557_DDP535C5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/7.1.53","article-title":"Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease","volume":"7","author":"Bijvoet","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522140557_DDP535C6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1525-0016(02)90716-1","article-title":"Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme","volume":"6","author":"Raben","year":"2002","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170522140557_DDP535C7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"key\n\t\t\t\t20170522140557_DDP535C8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1010383421286","article-title":"Enzyme therapy for Pompe disease with recombinant human alpha-glucosidase from rabbit milk","volume":"24","author":"Van den Hout","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"key\n\t\t\t\t20170522140557_DDP535C9","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet. Med."},{"key":"key\n\t\t\t\t20170522140557_DDP535C10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10545-007-0519-9","article-title":"Glycogen storage disease types I and II: treatment updates","volume":"30","author":"Koeberl","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 1","key":"key\n\t\t\t\t20170522140557_DDP535C11","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1007\/BF02680006","article-title":"Enzyme therapy for Pompe disease: from science to industrial enterprise","volume":"161","author":"Reuser","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"key\n\t\t\t\t20170522140557_DDP535C12","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab. Invest."},{"key":"key\n\t\t\t\t20170522140557_DDP535C13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymthe.2004.09.017","article-title":"Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers","volume":"11","author":"Raben","year":"2005","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170522140557_DDP535C14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ymgme.2007.04.018","article-title":"Differential muscular glycogen clearance after enzyme replacement therapy in a mouse model of Pompe disease","volume":"91","author":"Hawes","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"key\n\t\t\t\t20170522140557_DDP535C15","first-page":"424","article-title":"Expression of the insulin-like growth factor-II\/mannose-6-phosphate receptor in multiple human tissues during fetal life and early infancy","volume":"75","author":"Funk","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170522140557_DDP535C16","doi-asserted-by":"crossref","first-page":"16733","DOI":"10.1016\/S0021-9258(19)84766-X","article-title":"Developmental expression of the tissue insulin-like growth factor II\/mannose 6-phosphate receptor in the rat. Measurement by quantitative immunoblotting","volume":"264","author":"Sklar","year":"1989","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522140557_DDP535C17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ymthe.2006.08.009","article-title":"Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease","volume":"14","author":"Fukuda","year":"2006","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170522140557_DDP535C18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522140557_DDP535C19","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1093\/hmg\/ddn290","article-title":"Modulation of glycogen synthesis by RNA interference: towards a new therapeutic approach for glycogenosis type II","volume":"17","author":"Douillard-Guilloux","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522140557_DDP535C20","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1128\/MCB.24.16.7179-7187.2004","article-title":"Abnormal cardiac development in the absence of heart glycogen","volume":"24","author":"Pederson","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170522140557_DDP535C21","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.2337\/diabetes.54.12.3466","article-title":"Glucose metabolism in mice lacking muscle glycogen synthase","volume":"54","author":"Pederson","year":"2005","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170522140557_DDP535C22","doi-asserted-by":"crossref","first-page":"17260","DOI":"10.1074\/jbc.M410448200","article-title":"Exercise capacity of mice genetically lacking muscle glycogen synthase: in mice, muscle glycogen is not essential for exercise","volume":"280","author":"Pederson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522140557_DDP535C23","doi-asserted-by":"crossref","first-page":"10707","DOI":"10.1073\/pnas.93.20.10707","article-title":"Increased glycogen accumulation in transgenic mice overexpressing glycogen synthase in skeletal muscle","volume":"93","author":"Manchester","year":"1996","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522140557_DDP535C24","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0006-291X(03)00862-3","article-title":"Overexpression of glycogen synthase in mouse muscle results in less branched glycogen","volume":"305","author":"Pederson","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"key\n\t\t\t\t20170522140557_DDP535C25","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.56.12.1739","article-title":"Surprises of genetic engineering: a possible model of polyglucosan body disease","volume":"56","author":"Raben","year":"2001","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170522140557_DDP535C26","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1073\/pnas.86.12.4489","article-title":"Direct observation of glycogen synthesis in human muscle with 13C NMR","volume":"86","author":"Jue","year":"1989","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522140557_DDP535C27","first-page":"45","article-title":"Role of autophagy in the pathogenesis of Pompe disease","volume":"26","author":"Raben","year":"2007","journal-title":"Acta Myol."},{"key":"key\n\t\t\t\t20170522140557_DDP535C28","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/diab.30.12.1000","article-title":"The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization","volume":"30","author":"DeFronzo","year":"1981","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170522140557_DDP535C29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1097-2765(00)80155-0","article-title":"A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance","volume":"2","author":"Bruning","year":"1998","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20170522140557_DDP535C30","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI8305","article-title":"Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle","volume":"105","author":"Kim","year":"2000","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170522140557_DDP535C31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/78693","article-title":"Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance","volume":"6","author":"Zisman","year":"2000","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522140557_DDP535C32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI10294","article-title":"Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4","volume":"108","author":"Kim","year":"2001","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170522140557_DDP535C33","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1172\/JCI18526","article-title":"Tissue glycogen content and glucose intolerance","volume":"111","author":"Kasuga","year":"2003","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170522140557_DDP535C34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1748-1716.1967.tb03720.x","article-title":"Diet, muscle glycogen and physical performance","volume":"71","author":"Bergstrom","year":"1967","journal-title":"Acta Physiol. Scand."},{"key":"key\n\t\t\t\t20170522140557_DDP535C35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0278-5919(05)70162-9","article-title":"Role of carbohydrate in physical activity","volume":"18","author":"Ivy","year":"1999","journal-title":"Clin. Sports Med."},{"key":"key\n\t\t\t\t20170522140557_DDP535C36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1152\/jappl.1971.31.2.203","article-title":"Diet, muscle glycogen, and endurance performance","volume":"31","author":"Karlsson","year":"1971","journal-title":"J. Appl. Physiol."},{"key":"key\n\t\t\t\t20170522140557_DDP535C37","first-page":"1521","article-title":"Glycogen storage diseases","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Chen","year":"2001"},{"key":"key\n\t\t\t\t20170522140557_DDP535C38","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa066691","article-title":"Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0","volume":"357","author":"Kollberg","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522140557_DDP535C39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ymgme.2009.07.012","article-title":"Identification of a novel mutation in GYS1 (muscle-specific glycogen synthase) resulting in sudden cardiac death, that is diagnosable from skin fibroblasts","volume":"98","author":"Cameron","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"key\n\t\t\t\t20170522140557_DDP535C40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/NEN.0b013e3181815994","article-title":"Temporal neuropathologic and behavioral phenotype of 6neo\/6neo Pompe disease mice","volume":"67","author":"Sidman","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"key\n\t\t\t\t20170522140557_DDP535C41","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522140557_DDP535C42","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1182\/blood-2007-02-075960","article-title":"Oral maintenance clinical trial with Miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement","volume":"110","author":"Elstein","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170522140557_DDP535C43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/002215540505300108","article-title":"High resolution light Microscopy (HRLM) and digital analysis of Pompe disease pathology","volume":"53","author":"Lynch","year":"2005","journal-title":"J. Histochem. Cytochem."},{"key":"key\n\t\t\t\t20170522140557_DDP535C44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1242\/jcs.107.3.487","article-title":"Expression and cellular localization of glucose transporters (GLUT1, GLUT3, GLUT4) during differentiation of myogenic cells isolated from rat foetuses","volume":"107","author":"Guillet-Deniau","year":"1994","journal-title":"J. Cell Sci."},{"key":"key\n\t\t\t\t20170522140557_DDP535C45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00441-008-0640-6","article-title":"Genetic inactivation of acetylcholinesterase causes functional and structural impairment of mouse soleus muscles","volume":"333","author":"Vignaud","year":"2005","journal-title":"Cell Tissue Res."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/19\/4\/684\/17251225\/ddp535.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T10:33:06Z","timestamp":1634293986000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddp535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,3]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,12,3]]},"published-print":{"date-parts":[[2010,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddp535","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12,3]]}}}